Bayesian Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-42,000
| Closed | -$31K | – | 808 |
|
|
2024
Q4 | $31K | Buy |
+42,000
| New | +$31K | ﹤0.01% | 643 |
|
|
2024
Q1 | – | Sell |
-32,119
| Closed | -$49.1K | – | 971 |
|
|
2023
Q4 | $49.1K | Buy |
+32,119
| New | +$49.1K | 0.01% | 678 |
|
|
2021
Q1 | – | Sell |
-16,300
| Closed | -$56K | – | 630 |
|
|
2020
Q4 | $56K | Buy |
+16,300
| New | +$56K | 0.01% | 425 |
|
|
2016
Q1 | – | Sell |
-11,700
| Closed | -$156K | – | 400 |
|
|
2015
Q4 | $156K | Buy |
+11,700
| New | +$156K | 0.22% | 196 |
|